FDA label
What is rufinamide used for?
The FDA-approved uses of rufinamide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Rufinamide tablets are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted rufinamide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Rufinamide, tablet, film coated
Indications and Usage, quoted from the label by Aurobindo Pharma Limited (ANDA217230). Cross-references to other label sections are left out.
Rufinamide tablets are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.
Source: DailyMed label, set id d9ffc833-d902-41cb-8e8e-6bbba8e65b9e, version 2, effective July 19, 2025. NDC 59651-616, one of 10 listings for this product.
Questions
What is rufinamide used for?
The FDA label says: “Rufinamide tablets are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.